Esther, a leading researcher in the field, is discussing how stem cells are revolutionising healthcare by offering potential cures for cancer and other global diseases. Her work includes using stem cells in anticancer therapies and as models to study Charcot-Marie-Tooth disease type 1A.
Our partner's human Trophoblast Stem Cell (hTSC) Exosome product was used by the NIH to research exosomes.
Byron Mui, a graduate student at the NIH, is exploring how stem cells play a pivotal role in healing broken bones and injuries. His research underscores the transformative potential of stem cells in regenerative medicine.
Copyright © 2024 Biomedica Co., Ltd. - All Rights Reserved.